CHI3L1 and metabolic dysfunction-associated steatotic liver disease: When holding all other variables in the model constant the probability of NAFLD declined from 57% to 2% as the concentration of log10 YKL-40 increased from 1 to 2.33 ng/mL (Figure 3 panel A).